Results 31 to 40 of about 900 (120)
We describe our experience with a 12 year-old girl with kaposiform hemangioendothelioma accompanied by Kasabach–Merritt phenomenon with exacerbation of the disease 10 years after the initial diagnosis. Kaposiform hemangioendothelioma infiltrated into the
Naoki Sakata +5 more
doaj +1 more source
Kaposiform hemangioendothelioma with satellitosis and Kasabach-Merritt phenomenon
Kaposiform hemangioendothelioma is a rare, potentially life-threatening vascular tumor often associated with a coagulopathy known as Kasabach–Merritt phenomenon (KMP).
Asit Mittal +4 more
doaj +1 more source
Kaposiform hemangioendothelioma involving whole of a leg in a neonate with Kasabach-Merritt phenomenon causing limb and life-threatening situation has not been reported.
Anoop Subash +4 more
doaj +1 more source
Kaposiform haemangioendothelioma (KHE): Not just a bruise
Kaposiform haemangioendothelioma is a rare, but potentially fatal vascular tumour of childhood. We present a case that highlights the diagnostic and management challenges of this condition, particularly when associated with Kasabach–Merritt phenomenon ...
J. May +4 more
doaj +1 more source
Successful Management of Visceral Kaposiform Hemangioendothelioma with Kasabach‐Merritt Phenomenon Using Corticosteroids and Vincristine [PDF]
Kaposiform hemangioendothelioma (KHE) is a rare, locally aggressive vascular neoplasm that often develops a coagulopathy known as KasabachMerritt phenomenon (KMP). Visceral involvement denotes a poor prognosis.
Mi Hyeon Gang +2 more
doaj +1 more source
Pharmacological Treatment Leading to Complete Resolution in Kasabach-Merritt Phenomenon-Case Report
Kasabach-Merritt syndrome is a rare vascular tumor usually seen in infancy. It is locally aggressive and infiltrates the skin, subcutaneous tissue, and muscles. It is characterized by coagulopathy with thrombocytopenia, microangiopathic hemolytic anemia,
Jenith Vijayalakshmi +5 more
doaj +1 more source
Outcomes of Live Virus Vaccination in Patients With Vascular Anomalies Being Treated With Sirolimus
ABSTRACT Background Live vaccination in patients with vascular anomalies (VA) receiving sirolimus remains controversial due to immunosuppressive effects and theoretical risks. Procedure This single‐center retrospective study included patients with VA less than 4 years old at the start of sirolimus therapy who were incompletely vaccinated.
Svatava Merkle +5 more
wiley +1 more source
Kaposiform hemangioendothelioma: Diagnosis and treatment
Vascular endothelial growth factor‐C (VEGF‐C)/vascular endothelial growth factor receptor‐3 (VEGFR‐3) and angiopoietin‐2 (Ang‐2)/tyrosine kinase with immunoglobulin‐like and EGF‐like domain 2 (TIE2) signaling pathways play an important role in lymphangiogenesis.
Yi Tian +5 more
wiley +1 more source
Vincristine, aspirin, and prednisolone therapy in Kasabach–Merritt phenomenon: Response in 2 cases
Kasabach–Merritt phenomenon (KMP) is a severe thrombocytopenic coagulopathy which usually occurs in the presence of enlarging vascular tumors such as kaposiform hemangioendothelioma (KHE) and tufted angioma.
Shikha Gupta +3 more
doaj +1 more source
Kasabach-Merritt phenomenon is a process where the presence of vascular irregularity within a Kaposiform hemangioendothelioma or tufted angioma leads to constitutive coagulation factor activation and the development of chronic disseminated intravascular ...
Leo Reap +3 more
doaj +1 more source

